Family Medicine · Philadelphia, PA
NPI
1215236484
Since 2011
Specialty
Family Medicine
Code 207Q00000X
Group practices
4
Medicare group memberships
Hospitals
1
Hospital affiliations
10 Shurs Ln Ste 203
Philadelphia, PA, 19127
Phone (215) 482-1234
Groups this clinician bills Medicare through
Medicare paid, 2024
$63K
697 services
Medicare patients, 2024
175
Average age 79
Drug cost, 2024
$689K
8,176 prescriptions
Company payments, 2025
$17.43
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amanda Z de la Paz was code 99309 (snf e&m), 207 times for 59 patients. In total Amanda Z de la Paz billed 697 services in 36 codes, and Medicare paid $63K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-05-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99309 SNF E&M | Facility | 207 | 59 | $83.84 | $17K |
| 99310 SNF E&M | Facility | 104 | 41 | $121.87 | $13K |
| 99214 Office E&M - Established | Office | 81 | 45 | $86.49 | $7,006 |
| 99349 Home E&M - New and Established | Office | 52 | 26 | $89.84 | $4,672 |
| 99213 Office E&M - Established | Office | 45 | 36 | $64.33 | $2,895 |
| 99306 SNF E&M | Facility | 36 | 33 | $147.61 | $5,314 |
| 99308 SNF E&M | Facility | 20 | 15 | $54.49 | $1,090 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 16 | 16 | $133.64 | $2,138 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 14 | 12 | $11.46 | $160 |
| 99350 Home E&M - New and Established | Office | 14 | 13 | $120.27 | $1,684 |
| 99348 Home E&M - New and Established | Office | 13 | 11 | $60.94 | $792 |
| G0008 Administration of influenza virus vaccine | Office | 11 | 11 | $33.29 | $366 |
By year: 2022 $44K for 473 services; 2023 $57K for 583 services; 2024 $63K for 697 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 14 | 12 | $2.95 | $41.28 |
Medicare prescription drug claims, 2024
In 2024, the drug Amanda Z de la Paz prescribed most often to Medicare patients was Atorvastatin Calcium, with 490 prescriptions and refills. In total Amanda Z de la Paz wrote 8,176 Medicare prescriptions that cost $689K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 490 | 676 | 78 | $6,524 |
| Furosemide Generic | 416 | 439 | 36 | $2,278 |
| Levothyroxine Sodium Generic | 404 | 462 | 52 | $5,360 |
| Gabapentin Generic | 332 | 372 | 47 | $4,514 |
| Lisinopril Generic | 264 | 301 | 35 | $2,433 |
| Metoprolol Succinate Generic | 241 | 285 | 29 | $3,714 |
| Eliquis Apixaban | 225 | 228 | 23 | $88K |
| Amlodipine Besylate Generic | 223 | 327 | 48 | $2,221 |
| Mirtazapine Generic | 220 | 228 | 25 | $4,291 |
| Omeprazole Generic | 197 | 233 | 31 | $2,308 |
| Potassium Chloride Generic | 143 | 151 | 15 | $3,427 |
| Sertraline Hcl Generic | 136 | 146 | 17 | $1,172 |
| Duloxetine Hcl Generic | 132 | 149 | 14 | $6,040 |
| Rosuvastatin Calcium Generic | 129 | 151 | 18 | $3,851 |
| Pantoprazole Sodium Generic | 122 | 139 | 19 | $1,913 |
Brand drugs: 877 claims; generic drugs: 7,284 claims; opioid claims: 152.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amanda Z de la Paz $17.43 ($17.43 in general payments such as food, travel and fees) from 1 company. The largest payer was La Jolla Pharmaceutical Company with $17.43.
| Company | Payments | Amount |
|---|---|---|
| La Jolla Pharmaceutical Company | 1 | $17.43 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.